Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 60 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE DE LA CHAPELLE from Perwez, company number BE0453011081, closed financial year 2025 with a result of € 145 after tax. For that financial year PHARMACIE DE LA CHAPELLE recorded a gross margin of € 534,442 and equity of € 300,717. Compared with financial year 2024, the result moved from € 47,871 to € 145. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.
€ 300,717
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 145
▼ € 47,726 vs 2024
Profit after tax over the fiscal year.
€ 158,013
▼ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 238,717.
People and assets in 2025
5.6
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 457,212
▲ 17% vs 2024
€ 81,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 47,680
▲ € 43,041 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 207,751
▼ 25% vs 2024
€ 39,138 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 361,004
Supplier invoices still open on the last day of the fiscal year.
€ 71,007
▲ 9% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 538,098 | € 513,805 | € 531,184 | € 534,442 | ▲ 1% |
| Profit after taxes | € 90,092 | € 20,104 | € 47,871 | € 145 | ▼ € 47,726 |
| Equity | € 232,598 | € 252,702 | € 300,572 | € 300,717 | |
| Total debts | € 1,071,653 | € 1,192,005 | € 946,561 | € 990,070 | ▲ 5% |
| Cash | € 167,672 | € 48,866 | € 168,639 | € 158,013 | ▼ 6% |
| Land & buildings | € 529,844 | € 495,758 | € 468,899 | € 434,943 | ▼ 7% |
| Retained profit | € 170,598 | € 190,702 | € 238,572 | € 238,717 | |
| Bank debt | € 441,299 | € 360,016 | € 275,709 | € 207,751 | ▼ 25% |
| Balance sheet total | € 1,304,251 | € 1,444,707 | € 1,247,134 | € 1,290,787 | ▲ 4% |
| Employees (FTE) | 5.5 | 5.3 | 5.4 | 5.6 | ▲ 0.2 |
Key figures of PHARMACIE DE LA CHAPELLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE LA CHAPELLE?
What happened at PHARMACIE DE LA CHAPELLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 145 (▼ € 47,726 vs 2024). filed late Source: NBB ↗
- New establishment in Perwez. KBO
- Start of the company according to the CBE. KBO
In short
From € 90,092 profit in 2022 to € 145 profit in 2025.
Paid € 71,414 in corporate taxes since 2022.
Best year ever: 2022, with € 90,092 profit.
On average € 95,400 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE LA CHAPELLE? We notify you, reason included.
Follow PHARMACIE DE LA CHAPELLEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE DE LA CHAPELLE are Pierre Ancia, FINANCIA PHARMA and Justin Ancia. Pierre Ancia is also behind LOUVIMAR, KI LAIT CRU, FINANCIA PHARMA and Pharmacie de la Linière. FINANCIA PHARMA is also behind LOUVIMAR and Pharmacie de la Linière.
Directors
According to the 2025 annual accounts
Pierre Ancia
Director
Also active at: LOUVIMAR, KI LAIT CRU, FINANCIA PHARMA, Pharmacie de la Linière
Director · represented by Pierre Ancia
Also active at: LOUVIMAR, Pharmacie de la Linière
Justin Ancia
Director
Establishments
Establishment units
Physical locations of this company
Rue de la Chapelle 35
1360 Perwez
Chaussée de Charleroi 41
1360 Perwez
Active since 12 December 1994
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0453.011.081
- VAT number
- BE 0453.011.081
- Registered office
- Rue de la Chapelle 35, 1360 Perwez
- Names & denominations
- PHARMACIE DE LA CHAPELLE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 July 1994
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers